Saing, Jocile .

HRN: 23-75-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/20/2026
04/27/2026
IV
4.5g
Q8
DM Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: